Skip to content
July 29, 2026
  • TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration
  • HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu
  • Haryana Issues Standard Operating Guidelines for Withdrawal of Life Support
  • Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Capivasertib

Capivasertib

President
  • Global Healthcare

New Breast Cancer Drug Capivasertib Approved for NHS Use in the UK

tishha_newsApril 12, 2025April 12, 202503 mins

A new medication that can help slow the progression of an incurable form of breast cancer has been approved for…

Read More

Most Viewed

News
TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration
TISHHA Consultants LLP proudly marks its 2nd Foundation Day, celebrating…
News
HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu
HDFC Bank, under its flagship CSR programme Parivartan, has joined…

Random

1

TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration

  • News
2

HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu

  • News
3

Haryana Issues Standard Operating Guidelines for Withdrawal of Life Support

  • News
4

Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits

  • News
5

IMA CGP South Zone Conference 2026 Successfully Held in Kozhikode

  • News
6

CAG Flags Non-Functional Oxygen Plants and Unspent COVID Funds in West Bengal

  • News
7

SGPGI Launches Advanced OPD Lab for Head and Neck Cancer Care

  • News
8

First Human Receives Experimental Vaccine Against Rare Bundibugyo Ebola Virus

  • Global Healthcare
tishha_logo
TISHHA News Developed By BlazeThemes.